BCDA- Biocardia, Inc.

Name: Biocardia, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Altman Peter	280.8K	$308.8K	+6.0K
VP	Gillis Edward M	47.0K	$51.8K	-
CFO	McClung David	46.3K	$51.0K	-
Dir	Facteau Bill	15.7K	$17.3K	-
Dir	Moyes Jay M	15.6K	$17.1K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 23, 2025	McClung David	Chief Financial Officer	Buy	13,123	$1.90	$24,999.32	+43.7%	+23.5%	-37.0%
Apr 23, 2025	Altman Peter48	President And CEO	Buy	26,246	$1.90	$49,998.63	+23.3%	+23.5%	-37.0%
Apr 23, 2025	Blank Andrew Scott47	Director	Buy	131,233	$1.91	$249,998.87	+97.4%	+23.5%	-37.0%
Apr 23, 2025	Facteau Bill	Director	Buy	13,123	$1.90	$24,999.32	New	+23.5%	-37.0%
Apr 23, 2025	Krasno Richard M	Director	Buy	13,123	$1.90	$24,999.32	+417.3%	+23.5%	-37.0%
Apr 15, 2025	Altman Peter48	President And CEO	Buy	100	$2.14	$214.00	-	+13.7%	-42.4%
Apr 11, 2025	Altman Peter48	President And CEO	Buy	600	$2.01	$1,206.00	+0.3%	+22.5%	-40.3%
Apr 7, 2025	Altman Peter48	President And CEO	Buy	500	$1.96	$980.00	+0.4%	+5.8%	-40.1%
Apr 4, 2025	Altman Peter48	President And CEO	Buy	800	$2.04	$1,632.00	+0.7%	+5.5%	-41.3%
Apr 3, 2025	Altman Peter48	President And CEO	Buy	1,200	$2.24	$2,688.00	+1.1%	-0.8%	-42.9%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC